From May 12, 2022 to June 30, 2022, the company has repurchased 797,000 shares, representing 0.14% for HKD 2.9 million. With this, the company has completed the repurchase of 797,000 shares, representing 0.14% for HKD 2.9 million under the buyback announced on May 12, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.48 HKD | +0.40% | +5.98% | -0.40% |
May. 28 | Essex Bio-Technology Limited Declares Final Dividend for the Year Ended 31 December 2023 | CI |
Mar. 19 | Essex Bio-Technology's 2023 Profit Jumps 22% on Higher Turnover | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.40% | 180M | |
+6.96% | 101B | |
+8.29% | 42.63B | |
+82.32% | 29.77B | |
-11.82% | 16.14B | |
+1.39% | 14.31B | |
-12.13% | 11.55B | |
+176.65% | 10.53B | |
+6.74% | 9.2B | |
-55.52% | 8.98B |
- Stock Market
- Equities
- 1061 Stock
- News Essex Bio-Technology Limited
- Tranche Update on Essex Bio-Technology Limited's Equity Buyback Plan announced on May 12, 2022.